AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...

EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling the impact of peptides known as 'Tregitopes ...

South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...

In part 4 of an interview with The American Journal of Managed Care®, Frederick L. Locke, MD, provides insight on the design ...